Page 14 - Jacobs School News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told Reuters. Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley said in an interview. New-York based Synchron is farther along in the process of testing its brain implant than...

Synchron plans to launch an online registry for patients interested in joining the trial

In anticipation of Monday’s total eclipse, The Spectrum spoke with five experts to discuss the upcoming phenomenon.

Two UB researchers are embarking on a study to explore the best ways to get fresh fruits and vegetables into the diets of those who struggle with good nutrition.

Talal discusses the integration of a facilitated telemedicine approach into opioid treatment centers in New York, giving people with opioid use disorder easier access to HCV treatment.